Investigation of serum IGF-I levels amongst diabetic and non-diabetic cats

Journal of Feline Medicine and Surgery

Volumn 6, Issue 3, 2004, Pages 149-155

  Starkey, S R ^a   Tan, K ^c   Church, D B ^b  

^a Department of Obstetrics Gynecology   (United States)

^b QUEEN MOTHER HOSPITAL FOR ANIMALS   (United Kingdom)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN C;

ACROMEGALY; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; CAT DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; FISHER EXACT TEST; GLUCOSE HOMEOSTASIS; INTERMETHOD COMPARISON; LONG TERM CARE; NONHUMAN; PATHOPHYSIOLOGY;

FELIDAE; FELIS CATUS; PRIMATES; RODENTIA;

EID: 2542554970     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2004.01.002     Document Type: Article

References (30)

1. Amiel, S.A., Sherwin, R.S., Hintze, R.L., Gertner, I.M., Press, M., Tamborlane, W.V., 1984. The effects of diabetes and its control on insulin-like growth factors in the young subject with type 1 diabetes. Diabetes 33, 1175-1179.
2. Bang, P., Bismar, K., Rosenfeld, R.G., Hall, K., 1994. Fasting affects serum insulin-like growth factor-I (IGFs) and IGF-binding proteins differently in patients with non-insulin-dependent diabetes mellitus versus healthy non-obese and obese subjects. Journal of Clinical Endocrinology and Metabolism 78, 960-967.
3. Barnes, A.J., Kohner, E.M., Johnston, D.G., Alberti, K.G., 1985. Severe retinopathy and mild carbohydrate intolerance: possible role of insulin deficiency and elevated growth hormone. Lancet 1, 1465-1468.
4. Batch, J.A., Baxter, R.C., Werther, G., 1991. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependant diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 73, 964-968.
5. Bismar, K., Fernqvist- Forbes, E., Wahren, J., Hall, K., 1994. The effects of insulin on the hepatic production of insulin-like growth factor binding protein-I (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. Journal of Clinical Endocrinology & Metabolism 79, 872-878.
6. Church, D.B., Watson, A.D., Emslie, D.R., Middleton, D.J., Tan, K., Wong, D., 1994. Effects of proligestone and megestrol on plasma adrenocorticotrophic hormone, insulin and insulin-like growth factor-1 concentrations in cats. Research in Veterinary Science 56(2), 175-178.
7. Clasey, J.L., Wettman, A., Patrie, J., Wellman, J.Y., Pezzoli, S., Bouchard, C., Thorner, M.O., Hartman, M.L., 2001. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. Journal of Clinical Endocrinology and Metabolism 86(8), 3845-3852.
8. Daughaday, W.H., Rotwein, P., 1989. Insulin-like growth factors I and II: Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrine Reviews 10, 68-91.
9. Dunger, D.N., Acerini, C.L., 1998. IGF-I and diabetes in adolescents. Diabetes and Metabolism 24, 101-107.
10. Dunger, D.N., Ahmed, L., Ong, K., 2002. Growth and body composition in type 1 diabetes mellitus. Hormone Research 58(Suppl 1), 66-71.
11. Feldman, E.C., Nelson, R.W., 1996. Diabetes mellitus, in: Feldman, E.C., Nelson, R.W. (Eds.), Canine and Feline Endocrinology and Reproduction, second ed. Philadelphia, W.B Saunders, pp. 339-391.
12. Froesch, E.R., Burgi, H., Ramseier, E.B., Bally, P., Labhart, A., 1963. Antibody suppressible and non-suppressible insulin-like activities in human serum and their physiological significance. An insulin assay with adipose tissue of increased precision and specificity. Journal of Clinical Investigation 43, 1816-1834.
13. Frystyk, J., Skjaerbaek, C., Vestbo, E., Fisker, S., Orskov, I.I., 1999. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes/Metabolism Research and Reviews 15, 314-322.
14. Ghigo, E., Gianotti, L., Aravat, E., Ramunni, J., Valetto, M.R., Broglio, F., Rolla, M., Cavagnini, F., Muller, E.E., 1999. Effects of recombinant human insulin-iike growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans. Journal of Clinical Endocrinology and Metabolism 84(1), 285-290.
15. Goossens, M.M.C., Nelson, R.W., Feldman, E.C., Griffey, S.M., 1998. Response to treatment and survival in 104 cats with diabetes mellitus (1985-1995). Journal of Veterinary Internal Medicine 12, 1-6.
16. Greco, D.S., Broussard, I.D., Peterson, M.E., 1995. Insulin therapy. Veterinary Clinics of North America Small Animal Practice 25, 252-257.
17. Hanaire-Broutin, H., Sallerin-Caute, B., Poncet, M.F., Tauber, M., Bastide, R., Rosenfeld, R., Tauber, J.P., 1996a. Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization. Diabetes and Metabolism 22, 245-250.
18. Hanaire-Broutin, H., Sallerin-Caute, B., Poncet, M.F., Tauber, M., Bastide, R., Chale, J.J., Rosenfeld, R., Tauber, I.P., 1996b. Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM. Diabetologia 39, 1498-1504.
19. Kjeldsen, H., Hansen, A.P., Lundbaek, K., 1975. Twenty-four-hour serum growth hormone levels in maturity-onset diabetics. Diabetes 24, 977-982.
20. Krans, H.M.J., 1999. Type 2 diabetes: overview and genetics, in: Turtle, J.R., Kaneko, T., Osato, S. (Eds.), Diabetes in the New Millennium. Sydney. The Endocrinology and Diabetes Research Foundation of the University of Sydney.
21. Lewitt, M.S., Hazel, S.J., Church, D.B., Watson, A.D.J., Powell, S.E., Tan, K., 2000. Regulation of insulin-like growth factor-binding protein-3 ternary complex in feline diabetes mellitus. Journal of Endocrinology 166, 21-27.
22. Link, K.R.S., Rand, J.S., 1996. Glucose toxicity in cats [abstract]. Journal of Veterinary Internal Medicine 10, 185.
23. Moses, A.C., Young, S.C.J., Morrow, L.A., O'Brien, M., Clemmons, D.R., 1996. Recombinant human insulin-like growth factor-I increases insulin sensitivity and improves glycaemic control in type 2 diabetes. Diabetes 45, 91-100.
24. Nelson, R.W., 1998. Disorders of the endocrine pancreas, in: Nelson, R.W., Cuto, C.G. (Eds.), Small Animal Internal Medicine, second ed. St. Louis, Mosby, pp. 734-774.
25. Norman, E.J., Mooney, C.T., 2000. Diagnosis and management of diabetes mellitus in five cats with somatotrophic abnormalities. Journal of Feline Medicine and Surgery 2(4), 183-190.
26. Rand, J.S., 1999. Current understanding of feline diabetes mellitus: Part 1, Pathogenesis. Journal of Feline Medicine and Surgery 1(3), 143-153.
27. Russell-Jones, D.L., Rattray, M., Wilson, V.J., Jones, R.H., Sonksen, P.H., Thomas, C.R., 1992. Intraperitoneal insulin is more potent than subcutaneous insulin at restoring hepatic insulin-like growth factor-I mRNA levels in the diabetic rat: a functional role for the portal vascular link. Joural of Molecular Endocrinology 9(3), 257-263.
28. Struble, A.L., Nelson, R.W., 1997. Non insulin-dependent diabetes mellitus in cats and humans. The Compendium on Continuing Education for the Practicing Veterinarian 19, 935-945.
29. Tan, K., Baxter, R.C., 1986. Serum IGF-I levels in adult diabetic patients: the effect of age. Journal of Clinical Endocrinology & Metabolism 63, 651-655.
30. Wheelhouse, N.M., Stubbs, A.K., Lomax, M.A., MacRae, J.C., Hazlerigg, D.G., 1999. Growth hormone and amino acid supply interact synergistically to control insulin-like growth factor-I production and gene expression in cultured ovine hepatocytes. Journal of Endocrinology 163(2), 353-361.